Impact of epidermal growth factor receptor protein and gene alteration on Taiwanese hepatocellular carcinomas.

Background and Aim Epidermal growth factor receptor ( EGFR) overexpression is associated with disease progression and poor survival in a variety of solid tumors. The role of EGFR in hepatocellular carcinoma ( HCC) remains controversial. Methods One hundred thirty-eight HCCs were analyzed for total EGFR (t- EGFR) and phospho- EGFR (p- EGFR) expression and gene amplification using immunohistochemistry and fluorescence in situ hybridization. The role of EGFR was analyzed in relation to the clinicopathological features. Results Weak to strong p- EGFR immunostaining was noted in 42 of the 138 HCCs. p- EGFR expression correlated with alcoholism ( P = 0.03) and chronic hepatitis B infection ( P = 0.041). There was no correlation between t- EGFR expression and any of the clinicopathological features. Amplification of the EGFR gene was not identified in the 138 HCCs, but 39.1% of the HCCs showed balanced polysomy of both the EGFR gene and centromere 7. Moreover, 65 tumors showed > 2.2 copies per tumor cell. EGFR copy number gain ( CNG) was significantly correlated with gender ( P = 0.0491), tumor grade ( P = 0.006), and vascular invasion ( P = 0.005). HCCs with EGFR CNG also had a poor recurrence-free survival ( RFS), as compared with HCCs without EGFR CNG ( P = 0.031). When exploring the impact of gender, a significant association of EGFR CNG was found with tumor grade ( P = 0.044) and cirrhosis ( P = 0.015) exclusively in the male group only; however, the OS and RFS analysis show no significant difference between male and female groups. Conclusions EGFR CNG was related to crucial clinicopathological features and early recurrence, indicating that EGFR CNG might be a poor prognosis factor for Taiwanese HCC. [ABSTRACT FROM AUTHOR]